Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C

Table 2 Treatment n (%)

Treatment data
Peginterferon α-2a
Dose: 180 mg	1014 (100)
At least one dose reduction of peginterferon	66 (7)1
At least one discontinuation of peginterferon	46 (81)
Ribavirin
Dose
800 mg/d	183 (18)
1000 mg/d	413 (41)
1200 mg/d	416 (41)
1400 mg/d	1 (0.1)
At least one dose reduction of ribavirin	66 (7)1
At least one discontinuation of ribavirin	56 (89)
Scheduled treatment duration
24 wk	234 (23)
48 wk	773 (77)

¹The percentage of patients with dose reduction of peginterferon α-2a and the frequency of patients with dose reduction of ribavirin coincide, but are not exactly the same patients. The frequencies presented correspond to valid percentages. Percentages may not add up to 100 due to rounding error.